1 Top TSX Stock to Buy in December

CloudMD is a rapidly growing company in a rapidly growing industry; the telehealth industry is expected to grow to $55 billion by 2025.

| More on:
healthcare pharma

Image source: Getty Images

The global pandemic has changed the face of healthcare, possibly forever.

While traditional appointments to visit a doctor’s office are on the decline, telehealth has become a booming business.

One company that is capitalizing on this trend is CloudMD Software & Services (TSXV:DOC). The company’s cloud-based platform currently serves 376 clinics, 3,000 licensed practitioners, and approximately three million registered patients.

Amazing growth in latest quarter

CloudMD recently released its third-quarter earnings.

Total revenue increased 55%, from the same period last year to $3.4 million. The company’s Software-as-a-Service (SaaS) revenue increased 22% to $0.4 million from the third quarter in 2019. The revenue generated from clinic services and pharmacies grew to $2.9 million compared to last year — an increase of 62%.

CloudMD’s net loss and comprehensive loss in the quarter totaled $2.7 million, or $0.02 per share, compared to $0.8 million, or $0.01, for the same period last year. Adjusted EBITDA came in at a loss of $1.3 million for the quarter compared to a loss of $0.1 million in the third quarter of 2019.


CloudMD has recently made several key acquisitions. These include Snapclarity, iMD, Benchmark and Re:Function.

According to CloudMD, these businesses will provide meaningful revenue and are fundamental to the company’s Enterprise Health Solutions Division. The acquisitions allow CloudMD to be one of the only healthcare technology companies to provide comprehensive primary and specialist care, mental health support, and educational resources on their proprietary platforms.

CloudMD has transitioned its acquisition strategy from primarily clinic services and pharmacies to companies providing the SaaS model digital services. These services provide a higher margin, which should have an impact on the bottom line.

Although the company is concentrating on acquiring SaaS companies, CloudMD did make a few key acquisitions of traditional clinics during the quarter.

In August, CloudMD finalized the acquisition of South Surrey Medical Inc. — an integrated medical clinic based in Metro Vancouver, BC. Also in August, CloudMD signed a share-purchase agreement to acquire majority interest in West Mississauga Medical Ltd., a comprehensive family medicine and specialist medical clinic.

The company ended the third quarter with cash and cash equivalents totaling $33.9 million. This gives CloudMD the ability to continue its buying spree.

According to Dr. Essam Hamza, CEO of CloudMD, the company plans to continue its aggressive acquisition growth strategy. Hamza commented, “We are well-funded after raising almost $60 million over the last few months, which will allow us to deploy capital on a robust pipeline of acquisition targets.”

The bottom line

CloudMD is a rapidly growing company in a rapidly growing industry; the telehealth industry is expected to grow to $55 billion by 2025.

Dr. Essam Hamza is confident the tremendous growth of CloudMD will continue for the next several years. Hamza said, “Based on our Q3 results, combined with recently completed and announced acquisitions, we currently have a solid annualized revenue run rate of $35 million; through planned accretive acquisitions and organic growth, we are confident that this run rate will continue to grow in 2021.”

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Cindy Dye has no position in any of the stocks mentioned.

More on Top TSX Stocks

four people hold happy emoji masks
Top TSX Stocks

Just Released: 5 Top Stocks to Buy in September 2023 [PREMIUM PICKS]

The hype has left the building on our featured stock -- and that makes it an incredible deal today.

Read more »

Top TSX stocks to buy august 2023
Top TSX Stocks

Just Released: 5 Top Stocks to Buy in August 2023 [PREMIUM PICKS]

Don't miss out on our featured stock, which looks cheap today on at least two levels.

Read more »

Stocks to buy in Canada in July 2023
Top TSX Stocks

Just Released: 5 Top Stocks to Buy in July 2023 [PREMIUM PICKS]

You can put your portfolio into summer mode (for the next decade) with the help of these five companies.

Read more »

TSX Today
Energy Stocks

TSX Today: What to Watch for in Stocks on Friday, July 21

Rallying oil and gas prices could lift TSX energy stocks at the open today.

Read more »

a person looks out a window into a cityscape
Top TSX Stocks

Just Released: The 5 Top Stocks to Buy in June 2023 [PREMIUM PICKS]

We're not the only investors who like these companies today. Even a CEO has been actively buying shares of one…

Read more »

Dividend Stocks

Is BCE Stock Still a Top Telecom Investment in Canada?

Canada’s telecoms can provide growth and income in a defensive shell. Let’s see if BCE is still a top telecom…

Read more »

analyze data
Dividend Stocks

How to Build a Diversified Portfolio With These Top TSX Stocks

Looking to diversify your portfolio? The market is full of stellar options to consider, including these top TSX stocks to…

Read more »

butterfly emerges from chrysalis
Top TSX Stocks

Just Released: The 5 Top Stocks to Buy in May 2023 [PREMIUM PICKS]

Our favourite ideas this month, including the single best way to invest in bank stocks.

Read more »